Over recent decades, systemic cancer therapy has undergone significant transformations due to breakthroughs in understanding cancer biology, immunology, and genetics. Consequently, patients with advanced-stage cancers are experiencing unprecedented survival rates. Personalized cancer therapy aims to optimize clinical outcomes by tailoring drug therapies to individual patients based on their tumor genetics and/or epigenetics, thereby minimizing the toxicity associated with ineffective treatments.
No takes yet. Share an insight, caveat, or question.
Bonglee Kim (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: